Try our Advanced Search for more refined results

Regeneron Pharmaceuticals, Inc. v. Merus N.V.

  1. July 11, 2018

    Merus Awarded $10.5M In Mouse Patent Fight

    A New York federal judge revealed Tuesday that she had granted Kirkland & Ellis LLP-backed Merus NV's bid to collect $10.5 million in costs and attorney and expert fees from Regeneron Pharmaceuticals Inc. in an infringement dispute over a genetically modified mouse patent, holding that the request was reasonable.

  2. June 26, 2018

    Regeneron Told To Pay Merus Atty Fees In Mice Patent Row

    A New York federal judge has ordered Regeneron Pharmaceuticals Inc. to pay attorneys' fees to Kirkland & Ellis LLP-backed Merus NV for its litigation misconduct in an infringement dispute over a genetically modified mouse patent, noting the not yet publicly filed opinion is of "particular public interest."

  3. March 26, 2018

    Regeneron Must Pay Attys' Fees After 'Severe Misconduct'

    Regeneron Pharmaceuticals Inc. must pay Kirkland & Ellis LLP-backed Merus NV attorneys' fees after engaging in "severe litigation misconduct" from the outset of infringement litigation over a patent for a genetically modified mouse, a New York federal judge ruled on Monday.

  4. August 10, 2015

    Regeneron Hid Docs From USPTO, Judge Finds In Merus Case

    Regeneron Pharmaceuticals Inc. withheld materials from the U.S. Patent and Trademark Office in order to secure a patent for genetically modified mice, a New York federal judge has found, adding yet another obstacle to the company's infringement suit against Dutch-based Merus BV.